Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

What Sponsors Get Wrong When Selecting A CRO
Gene therapy immunogenicity requires platforms, judgment, and regulatory fluency beyond ADA norms. Relying on biologics criteria creates gaps; CGT expertise ensures reliable, interpretable results.
Retention Through Intention — Designing Truly Patient-Centric Trials
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
The Bioanalysis CRO Selection Checklist Every Sponsor Should Use Before Signing An MSA
Choosing a CRO requires more than proposals. Assess reliability, automation, GLP rigor, scientific engagement, pricing clarity, and capacity to find partners who deliver defensible data on real timelines.
Why Use Scorecards To Make Vendor Selection Decisions
Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.

Continuity And Risk Mitigation Following Unexpected QPPV Resignation
5/26/2026

Rapid escalation and clear interim governance ensured compliance and operational continuity following an unexpected QPPV resignation, reducing inspection risk during a critical pharmacovigilance transition.
Tips And Tricks For Developing Rare Cancer Clinical Trials
2/6/2025

Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
Optimizing Site Activation To Accelerate Clinical Trials
6/5/2025

Clinical trial site activation delays are a major bottleneck in drug development, hampering trial timelines and funding flows. To reverse this trend, site-focused solutions are being prioritized.
Community-Focused Site Networks Increase Access And Trial Reach
9/23/2025

Community-based site networks enhance clinical trial equity by engaging diverse populations, improving enrollment, retention, and developing therapies effective across varied patient groups.
Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective
12/4/2025

Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.

Suite Success For CROs

Shorten start-up times for your research studies by eliminating manual spreadsheets once and for all. SuiteSuccess for CROs allows you to unify clinical applications to improve visibility and oversight across the organization.
Optimize Your Endpoint Adjudication On A Single Platform

Medidata Adjudicate is part of the Medidata Clinical Cloud™, and offers a cloud-based, end-to-end solution, with easily configurable modules enabling quick setup to manage endpoint adjudication in clinical trials. Medidata Adjudicate supports investigator sites, sponsors, CROs, data managers, and the CEC in collecting, managing, organizing, adjudicating and submitting clinical endpoint data.
Greenphire Clinical Finance Suite: Site Payments

Automate and simplify complex global investigator payments with a proven solution used across 80+ countries.
Accelerating Biologics Through Development Milestones

Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.
IQVIA Investigator Site Portal

IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) offers sponsors, CROs, and sites the ability to manage trials easily and efficiently, from beginning to end, by enabling users to communicate effortlessly with sites, design and execute goals, and provide reporting, trial metrics, and much more.